DCOY
Decoy Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.17
+0.00%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$2.59
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$4.46
- EPS estimate
- -$2.88
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +29.5%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$2.88 | -$4.46 | Miss -54.86% | — |
| May 8, 2026 | -$4.12 | -$4.18 | Miss -1.44% | — |
| Nov 14, 2025 | -$34 | -$1.81 | Beat 94.61% | — |
| Aug 12, 2025 | -$33 | -$6.75 | Beat 79.55% | — |
| May 14, 2025 | -$36 | -$15 | Beat 57.11% | — |
| Mar 21, 2025 | -$35 | -$9.90 | Beat 71.43% | $4.4K |
| Nov 14, 2024 | -$2.40 | -$11 | Miss -374.58% | — |
| Aug 9, 2024 | -$804 | -$36 | Beat 95.58% | — |
| Mar 22, 2024 | -$121 | -$26 | Beat 78.22% | $17.9K |
| Nov 9, 2023 | -$128 | -$78 | Beat 39.26% | — |
| Aug 10, 2023 | -$151 | -$172 | Miss -13.49% | — |
| May 11, 2023 | -$237 | -$267 | Miss -12.63% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026